首页
>>
产品中心
>>
抗体产品
>>
重组抗体
>
Anti-Human CD40LG Recombinant Antibody

Anti-Human CD40LG Recombinant Antibody

产品编号

YR1017

别名

科研级 Ruplizumab ( 卢利珠单抗 ), Anti-CD40LG Recombinant Antibody, Research Grade Ruplizumab

规格
  • 1mg
  • 5mg
产品介绍
Alias科研级 Ruplizumab ( 卢利珠单抗 ), Anti-CD40LG Recombinant Antibody, Research Grade Ruplizumab
Catalog NumberYR1017
Molecular NameRuplizumab
Size1mg, 5mg
ClonityMonoclonal
Purity>95% as determined by SDS-PAGE
Concentration1mg/ml
Antibody IsotypeIgG1 Kappa
FormulationPBS, pH7.5
BackgroundRuplizumab (trade name Antova) is a humanized monoclonal antibody intended for the treatment of rheumatic diseases like systemic lupus erythematosus and lupus nephritis. A study showed that the drug was associated with life-threatening thromboembolisms, while another study only found thrombocytopenia.
CAS Number220651-94-5
ApplicationIF, IP, Neut, FuncS, ELISA, FCM
Storage ConditionIt is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles.
RemarksThis product is for research use only.
Shipping ConditionShipped on ice packs.
Molecular Weight145.45 kDa
TargetCD40LG[Homo sapiens]

登录

还没有账号?立即注册

注册

已有账号?立即登录

立即询价